DC vaccination

BIOLOGICAL5 trials

Sponsors

Loyola University, Huashan Hospital, Radboud University Medical Center

Conditions

Colorectal CancerGlioblastoma MultiformeGliomaLynch SyndromeMelanomaNeoplasmsOvarian Cancer

Phase 1

Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI

Active, not recruitingNCT01885702

Radboud University Medical CenterColorectal Cancer

Start: 2010-10-31End: 2025-09-30Target: 25Updated: 2025-04-04

Preventive Dendritic Cell Vaccination for Lynch Syndrome

Not yet recruitingNCT07412197

Radboud University Medical CenterLynch Syndrome

Start: 2026-10-01End: 2036-06-01Target: 16Updated: 2026-08-19

Phase 2

Ovarian Dendritic Cell Vaccine Trial

Loyola UniversityOvarian Cancer

Start: 2008-10-31End: 2021-07-31Target: 36Updated: 2021-04-26

Study of DC Vaccination Against Glioblastoma

Huashan HospitalGlioblastoma Multiforme, Glioma, Neoplasms

Start: 2012-03-31End: 2021-02-01Target: 100Updated: 2020-09-09

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

CompletedNCT02285413

Radboud University Medical CenterMelanoma

Start: 2011-02-28End: 2016-04-30Updated: 2016-05-04

Related Papers

CTIM-07. PHASE IIB RANDOMIZED, BLINDED, CONTROLLED TRIAL EVALUATING NEOADJUVANT PD-1 BLOCKADE COMBINED WITH A2B5+ GLIOMA STEM-LIKE CELL LYSATE-LOADED DCV IN RECURRENT GLIOBLASTOMA (IDH1/2 -)- TRAIL IN PROGRESS

Neuro-Oncology2023-11-01

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

Cancer Immunology Immunotherapy2020-01-2458 citations

A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.

Journal of Clinical Oncology2015-05-20